Cargando…
Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332913/ https://www.ncbi.nlm.nih.gov/pubmed/32646713 http://dx.doi.org/10.1016/j.drugpo.2020.102834 |
| _version_ | 1783553631543361536 |
|---|---|
| author | Giommoni, Luca |
| author_facet | Giommoni, Luca |
| author_sort | Giommoni, Luca |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7332913 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73329132020-07-06 Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets Giommoni, Luca Int J Drug Policy Viewpoint Elsevier B.V. 2020-09 2020-07-03 /pmc/articles/PMC7332913/ /pubmed/32646713 http://dx.doi.org/10.1016/j.drugpo.2020.102834 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Viewpoint Giommoni, Luca Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets |
| title | Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets |
| title_full | Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets |
| title_fullStr | Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets |
| title_full_unstemmed | Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets |
| title_short | Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets |
| title_sort | why we should all be more careful in drawing conclusions about how covid-19 is changing drug markets |
| topic | Viewpoint |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332913/ https://www.ncbi.nlm.nih.gov/pubmed/32646713 http://dx.doi.org/10.1016/j.drugpo.2020.102834 |
| work_keys_str_mv | AT giommoniluca whyweshouldallbemorecarefulindrawingconclusionsabouthowcovid19ischangingdrugmarkets |